Walgreens' Pegus to discuss impact of diabetes management on healthcare costs

Walgreens' chief medical officer will discuss the evidence-based medicine design and impact of a diabetes management program delivered by pharmacists at both workplace and community pharmacies during an upcoming conference, the drug store chain said.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

© 2012 Drug Store News. All Rights Reserved.